Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia

• Status: Completed
• Trial end date: 2007-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the clinical cure rate (ratio of clinically cured patients to the total number of patients) of ceftobiprole medocaril versus a comparator in the treatment of patients with community-acquired pneumonia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Basilea Pharmaceutica
• Treatments: Ceftobiprole; Ceftobiprole medocaril; Ceftriaxone; Cephalosporins; Linezolid

Criteria

Inclusion Criteria:

• Patients suffering from community-acquired pneumonia severe enough to require hospitalization

• Female patients must be postmenopausal for at least 1 year, surgically sterile, or practicing an effective method of birth control before entry and throughout the study

Exclusion Criteria:

• Patients with known or suspected hypersensitivity to any related antibiotic medications

• Treatment with any experimental drug within 30 days before enrollment

• Prior enrollment in this study or any study with ceftobiprole medocaril